ArticleJournal of medicinal chemistry2014

Development of a bioavailable μ opioid receptor (MOPr) agonist, δ opioid receptor (DOPr) antagonist peptide that evokes antinociception without development of acute tolerance.

Henry I Mosberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.